164 related articles for article (PubMed ID: 29329823)
1. Atypical presentation of CMV pneumonia in a heart transplant patient.
Boussouar S; Campedel L; Noble PD; Turki MW; Calvo J; Pourcher V; Rolland-Debord C
Med Mal Infect; 2018 Mar; 48(2):151-153. PubMed ID: 29329823
[No Abstract] [Full Text] [Related]
2. Rhodococcus equi and cytomegalovirus pneumonia in a renal transplant patient: diagnosis by fine-needle aspiration biopsy.
Simsir A; Oldach D; Forest G; Henry M
Diagn Cytopathol; 2001 Feb; 24(2):129-31. PubMed ID: 11169894
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus pneumonia in a patient with breast cancer on chemotherapy: case report and review of the literature.
Breathnach O; Donnellan P; Collins D; McNicholas W; Crown J
Ann Oncol; 1999 Apr; 10(4):461-5. PubMed ID: 10370790
[TBL] [Abstract][Full Text] [Related]
4. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cytomegalovirus pneumonia in heart transplant recipients with 9(1,3-dihydroxy-2-proproxymethyl)-guanine (DHPG).
Watson FS; O'Connell JB; Amber IJ; Renlund DG; Classen D; Johnston JM; Smith CB; Bristow MR
J Heart Transplant; 1988; 7(2):102-5. PubMed ID: 2835468
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia.
Papazian L; Fraisse A; Garbe L; Zandotti C; Thomas P; Saux P; Pierrin G; Gouin F
Anesthesiology; 1996 Feb; 84(2):280-7. PubMed ID: 8602657
[TBL] [Abstract][Full Text] [Related]
7. [Good syndrome and cytomegalovirus pneumonia].
Makinson A; Corne P; Pellé C; Ben Hadj Salem M; Pouessel D; Landreau L; Jonquet O
Rev Med Interne; 2003 May; 24(5):330-1. PubMed ID: 12763181
[No Abstract] [Full Text] [Related]
8. Ventilator-associated cytomegalovirus organizing pneumonia in an immunocompetent critically ill patient.
Yu WL; Chen CM; Lee WY
J Microbiol Immunol Infect; 2017 Feb; 50(1):120-122. PubMed ID: 25641593
[No Abstract] [Full Text] [Related]
9. Comparison of Preemptive Therapy and Antiviral Prophylaxis for Prevention of Cytomegalovirus in Seropositive Liver Transplant Recipients.
Liu AW; Jutivorakool K; Fisher CE; Rakita RM; Reyes JD; Bhattacharya RB; Jerome KR; Limaye AP
Transplantation; 2018 Apr; 102(4):632-639. PubMed ID: 29215460
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients.
Potena L; Grigioni F; Magnani G; Lazzarotto T; Musuraca AC; Ortolani P; Coccolo F; Fallani F; Russo A; Branzi A
J Heart Lung Transplant; 2009 May; 28(5):461-7. PubMed ID: 19416774
[TBL] [Abstract][Full Text] [Related]
11. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
[TBL] [Abstract][Full Text] [Related]
12. Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients.
Len O; Gavaldà J; Aguado JM; Borrell N; Cervera C; Cisneros JM; Cuervas-Mons V; Gurguí M; Martin-Dávila P; Montejo M; Muñoz P; Bou G; Carratalà J; Torre-Cisneros J; Pahissa A;
Clin Infect Dis; 2008 Jan; 46(1):20-7. PubMed ID: 18171208
[TBL] [Abstract][Full Text] [Related]
13. Massive cytomegalovirus pneumonia and myocarditis in a renal transplant recipient: successful treatment with DHPG.
Shabtai M; Luft B; Waltzer WC; Anaise D; Rapaport FT
Transplant Proc; 1988 Jun; 20(3):562-3. PubMed ID: 2837853
[No Abstract] [Full Text] [Related]
14. Effect of CMV-immunoglobulins (cytotect biotest) prophylaxis on CMV pneumonia after lung transplantation.
Solidoro P; Delsedime L; Costa C; Bergallo M; Libertucci D; Ruffini E; Rinaldi M; Baldi S
New Microbiol; 2011 Jan; 34(1):33-6. PubMed ID: 21344144
[TBL] [Abstract][Full Text] [Related]
15. Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.
Mabilangan C; Preiksaitis JK; Cervera C;
Transpl Infect Dis; 2019 Feb; 21(1):e13015. PubMed ID: 30358023
[TBL] [Abstract][Full Text] [Related]
16. Fatal cytomegalovirus pneumonia after preemptive antiviral therapy in a renal transplant recipient.
Ketteler M; Preuschof L; Mertz A; Stöffler-Meilicke M; Schäfer H; Distler A; Offermann G
Clin Nephrol; 2000 Nov; 54(5):418-24. PubMed ID: 11105806
[TBL] [Abstract][Full Text] [Related]
17. Low-Dose Valacyclovir for Cytomegalovirus Infection Prophylaxis After a Heart Transplant.
Kervan U; Kucuker SA; Kocabeyoglu SS; Unal EU; Ozatik MA; Sert DE; Kavasoglu K; Tezer AY; Pac M
Exp Clin Transplant; 2016 Oct; 14(5):551-554. PubMed ID: 26976362
[TBL] [Abstract][Full Text] [Related]
18. Treatment and prophylaxis of cytomegalovirus disease.
Levinson ML; Jacobson PA
Pharmacotherapy; 1992; 12(4):300-18. PubMed ID: 1325636
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus pneumonia: presentation, diagnosis, and treatment.
Ljungman P
Semin Respir Infect; 1995 Dec; 10(4):209-15. PubMed ID: 8668848
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
